Movement Alert｜METIS TECHBIO-P Falls 8.74% in Regular Trading, October share capital update offers no new catalyst

Market Focus09:32

On November 13, METIS TECHBIO-P fell 8.74% in Regular Trading, trading at HK$9.27, with turnover of HK$58.25 million.

The latest disclosed item was the company’s October monthly share capital update, which showed no new issuance, repurchase, cancellation, or treasury share changes. Ordinary shares and H shares remained unchanged, registered capital stayed at RMB118,269,785, and public float compliance was maintained.

Recent background catalysts had included the company’s inclusion in the Hong Kong exchange’s artificial intelligence index and its strategic collaboration with Eli Lilly on an AI-driven extrahepatic LNP delivery platform. Under that collaboration, the company said it would receive an upfront payment in the low double-digit millions of U.S. dollars and could be eligible for up to US$1.1 billion in milestone payments plus tiered royalties, but the newest disclosure itself was neutral and did not add a fresh capital-markets catalyst.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment